Package Leaflet: Information for the User
Pregabalin Lesvi25 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information1. What Pregabalin Lesvi is and what it is used for2. What you need to know before you take Pregabalin Lesvi
Pregabalin belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain:pregabalin is used to treat long-standing pain caused by nerve damage. There are many diseases that can cause peripheral neuropathic pain, such as diabetes or shingles. The feeling of pain can be described as hot, burning, throbbing, shooting, stabbing, sharp, crampy, aching, tingling, numbness, and a feeling of pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can have an impact on physical and social activity and overall quality of life.
Epilepsy:pregabalin is used to treat certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe pregabalin for you to help treat your epilepsy when your current treatment is not controlling your condition. You should take pregabalin in addition to your current treatment. Pregabalin should not be taken alone but should always be taken in combination with other anti-epileptic treatments.
Generalized anxiety disorder:pregabalin is used to treat generalized anxiety disorder (GAD). The symptoms of GAD are prolonged and excessive worry and anxiety that are difficult to control. GAD can also cause restlessness or feeling on edge or irritability or muscle tension or sleep disturbance. This is different from the worries and concerns of everyday life.
Do not takePregabaline Lesvi
If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Dependence
Some people may become dependent on pregabalin (need to keep taking the medicine). They may have withdrawal effects when they stop taking pregabalin (see section 3, “How to take Pregabalin Lesvi” and “If you stop taking Pregabalin Lesvi”). If you are concerned that you may become dependent on pregabalin, it is important that you consult your doctor.
If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:
If you notice any of these signs, talk to your doctor to discuss the best care plan for you, including when it is appropriate to stop treatment and how to do it safely.
Children and adolescents
The safety and efficacy in children and adolescents (under 18 years) have not been established, so pregabalin should not be used in this age group.
TakingPregabalin Lesviwith other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregabalin and certain medicines may influence each other (interactions). When pregabalin is used with certain medicines that have a sedating effect (including opioids), these effects may be enhanced, leading to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with other medicines that contain:
Oxycodone – (used as a pain reliever)
Lorazepam – (used to treat anxiety)
Alcohol
This medicine can be taken with oral contraceptives.
TakingPregabalin Lesviwith food, drinks, and alcohol
Pregabalin tablets can be taken with or without food.
It is advised not to drink alcohol while taking pregabalin.
Pregnancy, breastfeeding, and fertility
Do not take pregabalin during pregnancy or breastfeeding, unless your doctor has told you to. The use of pregabalin during the first 3 months of pregnancy may cause birth defects in the fetus that require medical treatment. In a study reviewing data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 babies out of 100 had such birth defects. This compares to 4 babies out of 100 born to women not treated with pregabalin in the study. Birth defects have been reported, including facial defects (cleft lip or palate), eye, central nervous system (including brain), kidney, or genital defects.
An effective contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Pregabalin may cause dizziness, somnolence, and decreased concentration. Do not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
Always take this medicine exactly as your doctor has told you.
If you are not sure, ask your doctor or pharmacist. Do not take more medicine than prescribed.
Your doctor will determine the appropriate dose for you.
Pregabalin is for oral use only.
The tablet can be divided into equal doses.
Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:
If you think that the effect of pregabalin is too strong or too weak, talk to your doctor or pharmacist.
If you are an elderly patient (over 65 years old), you should take pregabalin as normal, unless you have kidney problems.
Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems.
Continue taking pregabalin until your doctor tells you to stop.
If you take morePregabalin Lesvithan you should
In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. As a result of taking more pregabalin than you should, you may feel drowsy, confused, agitated, or restless. Seizures and loss of consciousness (coma) have also been reported.If you forget to takePregabalin Lesvi
It is important that you take your pregabalin tablets regularly at the same time each day. If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. In that case, continue with your next dose as usual. Do not take a double dose to make up for forgotten doses.
If you stop takingPregabalin Lesvi
Do not stop taking pregabalin unless your doctor tells you to. If you are going to stop taking the treatment, this should be done gradually over a minimum of one week.
After stopping long-term or short-term treatment with pregabalin, you should know that you may experience certain side effects, called withdrawal effects. These effects include sleep problems, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of self-harm or suicide, pain, sweating, and dizziness. These effects may occur more frequently or severely if you have been taking pregabalin for a longer period. If you experience withdrawal effects, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The very frequent adverse effects that can affect more than 1 person in 10 are:
The frequent adverse effects that can affect more than 1 person in 100 are:
The infrequent adverse effects that can affect more than 1 person in 1,000 are:
The rare adverse effects that can affect less than 1 person in 1,000 are:
· Becoming dependent on Pregabalin ("drug dependence")
Once a short or long-term treatment with Pregabalin is finished, you should know that you may experience certain adverse effects, called withdrawal effects (see "If you stop treatment with Pregabalin Lesvi").
If you experience swelling in the face or tongue, or if your skin turns red and has blisters or peeling, you should seek medical attention immediately.
Certain adverse effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (stiff or rigid muscles), with similar adverse effects to those of Pregabalin, so the intensity of these effects may increase when taken together.
The following adverse reaction has been reported in post-marketing experience: difficulty breathing, shallow breathing.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after the abbreviation CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition ofPregabalina Lesvi
The active principle is pregabalin. Each tablet contains 25 mg of pregabalin.
The other components (excipients) are: microcrystalline cellulose and magnesium stearate.
Appearance of the product and package contents
Round, biconvex, scored tablet, white in color, marked with "I" on one face.
Pregabalina Lesvi is available in poliamide/Aluminum/polyvinyl chloride (PVC) blisters in cardboard boxes containing 56 tablets.
Only certain package sizes may be marketed.
Marketing authorization holder and manufacturerMarketing authorization holder
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
ManufacturerNeuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona 69
08970 Sant Joan Despí (Barcelona)
Spain
Date of the last revision of this prospectus: December 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/